Medpace Holdings, Inc. (MEDP)
587.68
+4.52
(+0.78%)
USD |
NASDAQ |
Sep 11, 16:00
587.68
0.00 (0.00%)
After-Hours: 17:09
Medpace Holdings Gross Profit (TTM) : 772.42M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 772.42M |
| March 31, 2026 | 750.49M |
| December 31, 2025 | 732.49M |
| September 30, 2025 | 705.12M |
| June 30, 2025 | 676.72M |
| March 31, 2025 | 650.32M |
| December 31, 2024 | 627.05M |
| September 30, 2024 | 586.08M |
| June 30, 2024 | 550.90M |
| March 31, 2024 | 522.10M |
| December 31, 2023 | 498.18M |
| September 30, 2023 | 478.18M |
| June 30, 2023 | 465.10M |
| March 31, 2023 | 440.76M |
| December 31, 2022 | 410.10M |
| September 30, 2022 | 382.78M |
| June 30, 2022 | 351.30M |
| March 31, 2022 | 327.27M |
| December 31, 2021 | 307.04M |
| September 30, 2021 | 301.89M |
| June 30, 2021 | 289.34M |
| March 31, 2021 | 271.91M |
| December 31, 2020 | 259.20M |
| Date | Value |
|---|---|
| September 30, 2020 | 239.21M |
| June 30, 2020 | 229.10M |
| March 31, 2020 | 235.93M |
| December 31, 2019 | 222.51M |
| September 30, 2019 | 216.36M |
| June 30, 2019 | 202.78M |
| March 31, 2019 | 187.81M |
| December 31, 2018 | 176.73M |
| September 30, 2018 | 157.77M |
| June 30, 2018 | 146.05M |
| March 31, 2018 | 133.24M |
| December 31, 2017 | 128.22M |
| September 30, 2017 | 125.61M |
| June 30, 2017 | 120.81M |
| March 31, 2017 | 118.72M |
| December 31, 2016 | 114.00M |
| September 30, 2016 | 111.00M |
| June 30, 2016 | 104.48M |
| March 31, 2016 | 75.55M |
| December 31, 2015 | 49.17M |
| September 30, 2015 | 22.49M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| IQVIA Holdings, Inc. | 4.42B |
| Charles River Laboratories International, Inc. | 1.305B |
| Avantor, Inc. | 2.012B |
| Champions Oncology, Inc. | 28.93M |
| Personalis, Inc. | 8.838M |